High dose dexamethasone as first line therapy of multiple myeloma? A case report

Recenti Progressi in Medicina

Volumn 89, Issue 1, 1998, Pages 18-20

  Meregalli, Maurizio ^a,b   Bertola, Giorgio ^a   Grando, Donata ^a  

^a SANTA CORONA HOSPITAL   (Italy)

^b S CROCE E CARLE HOSPITAL   (Italy)

Author keywords

Dexamethasone; Multiple myeloma; VAD based regimen

Indexed keywords

DEXAMETHASONE SODIUM PHOSPHATE; MELPHALAN; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

AGED; ARTICLE; BONE MARROW SUPPRESSION; CASE REPORT; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; MULTIPLE MYELOMA; ORAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEXAMETHASONE; DOXORUBICIN; FEMALE; HUMANS; MULTIPLE MYELOMA; TIME FACTORS; VINCRISTINE;

EID: 0031935801     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Alexanian R, Dimopulos MA, Delasalle K, Barlogie B. Primary dexamethasone treatment of multiple myeloma. Blood 1992; 80: 887-90.
2. Dimopulos MA, Weber D, Delasalle KB, Alexanian R. Combination therapy with interferon-dexamethasone for newly diagnosed patients with multiple myeloma. Cancer 1993; 72: 2589-92.
3. Alexanian R, Barlogie B, Tucker S. VAD-based regimens as primary treatment for multiple myeloma. Am J Hematol 1990; 33: 86-9.
4. Alexanian R, Barlogie B, Dixon D. High dose glucocorticoid treatment for resistant myeloma. Ann Int Med 1986; 105: 8-11.
5. McLaughlin P, Alexanian R. Myeloma protein kinetics following chemotherapy. Blood 1982; 60: 851-5.